Dirk‐Jan Reijngoud

13.1k citations

159 papers · 10.0k indexed · 3 hit papers · h-index 45

Clinical Biochemistry top 0.1%
- Metabolism and Genetic Disorders 69
Physiology top 0.5%
- Diet and metabolism studies 34
- Adipose Tissue and Metabolism 17
Biological Psychiatry top 1%
Molecular Biology top 1%
- Metabolism, Diabetes, and Cancer 18
- Mitochondrial Function and Pathology 18
- Metabolomics and Mass Spectrometry Studies 16
- Peroxisome Proliferator-Activated Receptors 14
Nutrition and Dietetics top 0.5%
Cell Biology
- Muscle metabolism and nutrition 17

Co-authors: Albert K. Groen Barbara M. Bakker Karen van Eunen Gijs den Besten Koen Venema Theo H. van Dijk J. M. Tager Rick Havinga
Cited by: Clinical Biochemistry Physiology Biological Psychiatry
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (5 papers)Journal of Clinical Investigation (1 paper)
Partner nations: Netherlands United States France

In The Last Decade

Dirk‐Jan Reijngoud

156 papers receiving 9.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Diabetes
2013 American Journal of Physiology-Gastrointestinal and Liver Physiology
2013 Journal of Lipid Research

Peers

Countries citing papers authored by Dirk‐Jan Reijngoud

Since Specialization

Citations

This map shows the geographic impact of Dirk‐Jan Reijngoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk‐Jan Reijngoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk‐Jan Reijngoud more than expected).

Fields of papers citing papers by Dirk‐Jan Reijngoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk‐Jan Reijngoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk‐Jan Reijngoud. The network helps show where Dirk‐Jan Reijngoud may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dirk‐Jan Reijngoud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk‐Jan Reijngoud Line = papers co-authored together Dirk‐Jan Reijngoud links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine Journal of Agricultural and Food Chemistry ·Mara P. H. van Trijp,Melany Ríos-Morales,Madelon J. Logtenberg,Shohreh Keshtkar,Lydia A. Afman,Ben Witteman,Barbara M. Bakker,Dirk‐Jan Reijngoud,Henk A. Schols,Guido Hooiveld	2024	4
2	Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD+ in medium-chain acyl-CoA dehydrogenase knockout mice Scientific Reports ·Anne-Claire M. F. Martines,Albert Gerding,Sarah Stolle,Marcel A. Vieira‐Lara,Justina C. Wolters,Angelika Jurdzinski,Laura Bongiovanni,Alain de Bruin,Pieter van der Vlies,Gerben van der Vries,Vincent W. Bloks,Terry G. J. Derks,Dirk‐Jan Reijngoud,Barbara M. Bakker	2019	7
3	From genome to phenome—Simple inborn errors of metabolism as complex traits Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·C. M. L. Touw,Terry G. J. Derks,Barbara M. Bakker,Albert K. Groen,Gerrit Smit,Dirk‐Jan Reijngoud	2014	7
4	In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes Orphanet Journal of Rare Diseases ·C. M. L. Touw,Gerrit Smit,Klary E. Niezen‐Koning,Conny Bosgraaf-de Boer,Albert Gerding,Dirk‐Jan Reijngoud,Terry G. J. Derks	2013	18
5	The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolismbreakdown → Journal of Lipid Research ·Gijs den Besten,Karen van Eunen,Albert K. Groen,Koen Venema,Dirk‐Jan Reijngoud,Barbara M. Bakker	2013	3650
6	Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis Orphanet Journal of Rare Diseases ·Martijn J. de Groot,Marieke Hoeksma,Dirk‐Jan Reijngoud,Harold W. de Valk,Anne M. J. Paans,Pieter J. J. Sauer,Francjan J. van Spronsen	2013	35
7	Competition between fatty-acid beta-oxidation enzymes makes the pathway vulnerable to substrate overload FEBS Journal ·van Karen Eunen,Sage Simons,Albert Gerding,Gijs den Besten,Nienke Touw,Dirk‐Jan Reijngoud,Bert Groen,Barbara M. Bakker	2012	1
8	Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study Orphanet Journal of Rare Diseases ·C. M. L. Touw,Gerrit Smit,Maaike de Vries,Johannis B.C. de Klerk,Annet M. Bosch,Gepke Visser,Margot F. Mulder,M. Estela Rubio‐Gozalbo,Bert Elvers,Klary E. Niezen‐Koning,Ronald J. A. Wanders,Hans R. Waterham,Dirk‐Jan Reijngoud,Terry G. J. Derks	2012	24
9	Diurnal variations in blood phenylalanine of PKU infants under different feeding regimes Molecular Genetics and Metabolism ·Margreet van Rijn,Marieke Hoeksma,Pieter J. J. Sauer,P. Modderman,Dirk‐Jan Reijngoud,Francjan J. van Spronsen	2011	6
10	Adult Patients with Well-Controlled Phenylketonuria Tolerate Incidental Additional Intake of Phenylalanine Annals of Nutrition and Metabolism ·Margreet van Rijn,Marieke Hoeksma,Pieter J. J. Sauer,P. Modderman,Dirk‐Jan Reijngoud,Francjan J. van Spronsen	2011	19
11	Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor– and Liver X Receptorα–Controlled Metabolic Pathways in Mice Hepatology ·Hilde Herrema,Maxi Meissner,Theo H. van Dijk,Gemma Brufau,Renze Boverhof,Maaike H. Oosterveer,Dirk‐Jan Reijngoud,Michael Müller,Frans Stellaard,Albert K. Groen,Folkert Kuipers	2009	81
12	An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr–/– Mice Journal of Biological Chemistry ·Theo H. van Dijk,Aldo Grefhorst,Maaike H. Oosterveer,Vincent W. Bloks,Bart Staels,Dirk‐Jan Reijngoud,Folkert Kuipers	2009	54
13	Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizures Seizure ·Laura K. Teune,J.H. vd Hoeven,Natasha M. Maurits,Arend F. Bos,Jan‐Willem C. Alffenaar,Dirk‐Jan Reijngoud,O.F. Brouwer,Deborah Sival	2007	3
14	Sustained activation of the mTOR nutrient sensing pathway associates with hepatic insulin resistance but not with steatosis per se in mice Diabetologia ·Elena Korsheninnikova,Gerard C.M. van der Zon,Peter J. Voshol,George M. C. Janssen,Louis M. Havekes,Aldo Grefhorst,Folkert Kuipers,Dirk‐Jan Reijngoud,J A Romijn,D. Margriet Ouwens,J. Antonie Maassen	2006	1
15	NORMAL PROTEIN METABOLISM IN PATIENTS WITH PHENYLKETONURIA Data Archiving and Networked Services (DANS) ·M. van Rijn,H. A. Kingma,P. Modderman,Dirk‐Jan Reijngoud,Pieter J. J. Sauer,Beate Szczerbak,van FrancJan Spronsen	2005	2
16	Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis Kidney International ·Monique G. de Sain-van der Velden,George A. Kaysen,Hugh A. Barrett,Frans Stellaard,Mireille M. Gadellaa,Hieronymus A.M. Voorbij,Dirk‐Jan Reijngoud,Ton J. Rabelink	1998	2
17	Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis Kidney International ·Monique G. de Sain-van der Velden,George A. Kaysen,Hugh A. Barrett,Frans Stellaard,Mireille M. Gadellaa,Hieronymus A.M. Voorbij,Dirk‐Jan Reijngoud,Ton J. Rabelink	1998	67
18	Plasma α2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone Kidney International ·Monique G.M. de Sain–van der Velden,Ton J. Rabelink,Dirk‐Jan Reijngoud,Mireille M. Gadellaa,Hieronymus A.M. Voorbij,Frans Stellaard,George A. Kaysen	1998	47
19	Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature European Journal of Pediatrics ·Klary E. Niezen‐Koning,Ronald J. A. Wanders,Jos P.N. Ruiter,Lodewijk IJlst,Gepke Visser,W. C. C. Reitsma-Bierens,H. S. A. Heymans,Dirk‐Jan Reijngoud,Gerrit Smit	1997	28
20	Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria American Journal of Clinical Nutrition ·FJ van Spronsen,Tessa van Dijk,GP Smit,M. van Rijn,Dirk‐Jan Reijngoud,R. Berger,HS Heymans	1996	38

About Dirk‐Jan Reijngoud

Dirk‐Jan Reijngoud is a scholar working on Clinical Biochemistry, Physiology and Biochemistry, having authored 159 papers that have together received 10.0k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (69 papers), Diet and metabolism studies (34 papers), Metabolism, Diabetes, and Cancer (18 papers), Mitochondrial Function and Pathology (18 papers), Muscle metabolism and nutrition (17 papers), Adipose Tissue and Metabolism (17 papers), Metabolomics and Mass Spectrometry Studies (16 papers) and Peroxisome Proliferator-Activated Receptors (14 papers). The work is most often cited by research in Clinical Biochemistry (1.5k citations), Physiology (3.6k citations) and Biological Psychiatry (285 citations). Dirk‐Jan Reijngoud has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Albert K. Groen, Barbara M. Bakker, Karen van Eunen, Gijs den Besten, Koen Venema, Theo H. van Dijk, J. M. Tager, Rick Havinga, Albert Gerding and Folkert Kuipers. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact